Note 29.13 Loans Disclosures pursuant to the Regulation 34(3) read with para A of Schedule V to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Section 186 (4) of the Companies Act, 2013. a) Loans (` cr) Particulars Maturity Interest rate p.a. Purpose Amount outstanding as at Maximum balance during the year March 31, 2025 March 31, 2024 2024-25 2023-24 i) Subsidiary companies: Atul Bioscience Ltd June 2025 8.80% For working capital, operational, project expenditure requirement and purchase of the manufacturing facility at Ambernath 2.50 12.53 12.53 54.55 Atul Finserv Ltd August 2024 9.05% Providing financial support to Anaven project - 25.00 25.00 25.00 Atul Products Ltd For project expenditure requirement - - - 769.95 Atul Rajasthan Date Palms Ltd February 2027 11.65% For working capital 8.00 4.00 4.00 4.00 ii) Joint operation of subsidiary company: Anaven LLP March 2026 9.75% to 10.85% For working capital, operational and project expenditure requirement 30.72 30.72 30.72 53.98 Notes: 1) Loans given to employees as per the policy of the Company are not considered. 2) The loanees did not hold any shares in the share capital of the Company. b) Details of investments made and guarantees provided are given in Note 5.1 and Note 29.1(b), respectively. Note 29.14 Disclosure requirement under MSMED Act, 2006 The Company has certain dues to suppliers (trade and capital) registered under the Micro, Small and Medium Enterprises Development Act, 2006 (MSMED Act). The disclosures pursuant to the said MSMED Act are as follows: (` cr) Particulars As at March 31, 2025 As at March 31, 2024 Principal amount due to suppliers registered under the MSMED Act and remaining unpaid as at year end 34.49 68.36 Interest due to suppliers registered under the MSMED Act and remaining unpaid as at year end 0.00 0.00 Principal amounts paid to suppliers registered under the MSMED Act, beyond the appointed day during the year 1.02 0.80 Interest paid, other than under Section 16 of the MSMED Act, to suppliers registered under the MSMED Act, beyond the appointed day during the year - - Interest paid, under Section 16 of the MSMED Act, to suppliers registered under the MSMED Act, beyond the appointed day during the year 0.01 0.01 Interest due and payable towards suppliers registered under MSMED Act, for payments already made - - Further interest remaining due and payable for earlier years - - 219 219 Corporate overview Performance overview ESG overview Statutory Reports Financial Statements
RkJQdWJsaXNoZXIy MjA2MDI2